139 related articles for article (PubMed ID: 30226549)
1. Circadian clock gene Per2 downregulation in non‑small cell lung cancer is associated with tumour progression and metastasis.
Xiang R; Cui Y; Wang Y; Xie T; Yang X; Wang Z; Li J; Li Q
Oncol Rep; 2018 Nov; 40(5):3040-3048. PubMed ID: 30226549
[TBL] [Abstract][Full Text] [Related]
2. LIMD2 targeted by miR‑34a promotes the proliferation and invasion of non‑small cell lung cancer cells.
Wang F; Li Z; Xu L; Li Y; Li Y; Zhang X; Wang Y; Liu D
Mol Med Rep; 2018 Nov; 18(5):4760-4766. PubMed ID: 30221696
[TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical significance of circadian gene Per2 in non-small cell lung cancer].
Chi C; He ZF; Liu Y; Lin XM; Sun CC
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):129-31. PubMed ID: 23714668
[TBL] [Abstract][Full Text] [Related]
4. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance.
Shen L; Yang M; Lin Q; Zhang Z; Zhu B; Miao C
Oncol Rep; 2016 Aug; 36(2):877-85. PubMed ID: 27373316
[TBL] [Abstract][Full Text] [Related]
5. KIAA0247 inhibits growth, migration, invasion of non-small-cell lung cancer through regulating the Notch pathway.
Xu Y; Ren H; Jiang J; Wang Q; Wudu M; Zhang Q; Su H; Wang C; Jiang L; Qiu X
Cancer Sci; 2018 Apr; 109(4):1055-1065. PubMed ID: 29451718
[TBL] [Abstract][Full Text] [Related]
6. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG
J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870
[TBL] [Abstract][Full Text] [Related]
7. Overexpression and biological function of TMEM48 in non-small cell lung carcinoma.
Qiao W; Han Y; Jin W; Tian M; Chen P; Min J; Hu H; Xu B; Zhu W; Xiong L; Lin Q
Tumour Biol; 2016 Feb; 37(2):2575-86. PubMed ID: 26392108
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑145 inhibits migration and induces apoptosis in human non‑small cell lung cancer cells through regulation of the EGFR/PI3K/AKT signaling pathway.
Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW
Oncol Rep; 2018 Nov; 40(5):2944-2954. PubMed ID: 30226581
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of Per1, Per2 and Per3 and their prognostic relevance in non-small cell lung cancer.
Liu B; Xu K; Jiang Y; Li X
Int J Clin Exp Pathol; 2014; 7(11):7863-71. PubMed ID: 25550826
[TBL] [Abstract][Full Text] [Related]
10. Increased HAGLR expression promotes non-small cell lung cancer proliferation and invasion via enhanced de novo lipogenesis.
Lu C; Ma J; Cai D
Tumour Biol; 2017 Apr; 39(4):1010428317697574. PubMed ID: 28443464
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen promotes cell proliferation and tumorigenesis by up-regulating STAT3 in non-small cell lung cancer.
Wang L; Kong W; Liu B; Zhang X
Biomed Pharmacother; 2018 Aug; 104():595-602. PubMed ID: 29803172
[TBL] [Abstract][Full Text] [Related]
12. The circadian clock gene PER2 plays an important role in tumor suppression through regulating tumor-associated genes in human oral squamous cell carcinoma.
Su X; Chen D; Yang K; Zhao Q; Zhao D; Lv X; Ao Y
Oncol Rep; 2017 Jul; 38(1):472-480. PubMed ID: 28535015
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
[TBL] [Abstract][Full Text] [Related]
14. HOXA5 indicates poor prognosis and suppresses cell proliferation by regulating p21 expression in non small cell lung cancer.
Zhang ML; Nie FQ; Sun M; Xia R; Xie M; Lu KH; Li W
Tumour Biol; 2015 May; 36(5):3521-31. PubMed ID: 25549794
[TBL] [Abstract][Full Text] [Related]
15. miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1.
Ye Z; Fang B; Pan J; Zhang N; Huang J; Xie C; Lou T; Cao Z
Oncol Rep; 2017 Jun; 37(6):3244-3252. PubMed ID: 28498463
[TBL] [Abstract][Full Text] [Related]
16. miR-768-3p is involved in the proliferation, invasion and migration of non-small cell lung carcinomas.
Xie Z; Chen W; Chen Y; Wang X; Gao W; Liu Y
Int J Oncol; 2017 Nov; 51(5):1574-1582. PubMed ID: 29048613
[TBL] [Abstract][Full Text] [Related]
17. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
18. miR‑145 inhibits human non‑small-cell lung cancer growth by dual-targeting RIOK2 and NOB1.
Liu K; Chen H; You Q; Ye Q; Wang F; Wang S; Zhang S; Yu K; Li W; Gu M
Int J Oncol; 2018 Jul; 53(1):257-265. PubMed ID: 29749434
[TBL] [Abstract][Full Text] [Related]
19. Decorin is responsible for progression of non-small-cell lung cancer by promoting cell proliferation and metastasis.
Shi X; Liang W; Yang W; Xia R; Song Y
Tumour Biol; 2015 May; 36(5):3345-54. PubMed ID: 25524578
[TBL] [Abstract][Full Text] [Related]
20. miR‑584‑5p regulates migration and invasion in non‑small cell lung cancer cell lines through regulation of MMP‑14.
Guo T; Zheng C; Wang Z; Zheng X
Mol Med Rep; 2019 Mar; 19(3):1747-1752. PubMed ID: 30628644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]